Inflammatory Bowel Disease: Diagnosis and TreatmentGary L. Gitnick |
From inside the book
Results 1-3 of 52
Page 289
... dosage treatment have yet to be performed . There is little evidence that high - dosage 5 - ASA therapy is superior to standard - dosage sulfasalazine therapy ( 2 to 4 g ) in patients who can tolerate sulfasalazine . The major advantage ...
... dosage treatment have yet to be performed . There is little evidence that high - dosage 5 - ASA therapy is superior to standard - dosage sulfasalazine therapy ( 2 to 4 g ) in patients who can tolerate sulfasalazine . The major advantage ...
Page 339
... DOSAGE AND MONITORING For the purpose of our controlled trial the initial dosage of 6 - MP was 1.5 mg / kg per day , as has been used in most earlier studies . Since completion of the trial ... dosage , it DRUG DOSAGE AND MONITORING 339 •
... DOSAGE AND MONITORING For the purpose of our controlled trial the initial dosage of 6 - MP was 1.5 mg / kg per day , as has been used in most earlier studies . Since completion of the trial ... dosage , it DRUG DOSAGE AND MONITORING 339 •
Page 341
... dosage . Dosages below 50 mg per day are 50 mg one day alternating with 25 mg the next day . A further reduction in dosage wold be 50 mg every other day . Concomitant corticosteroid therapy will raise the white blood count while 6 - MP ...
... dosage . Dosages below 50 mg per day are 50 mg one day alternating with 25 mg the next day . A further reduction in dosage wold be 50 mg every other day . Concomitant corticosteroid therapy will raise the white blood count while 6 - MP ...
Contents
Approaches to Management | 3 |
Epidemiology | 23 |
Where Have We Been? Where Are We Going? | 29 |
Copyright | |
32 other sections not shown
Other editions - View all
Common terms and phrases
5-aminosalicylic acid abdominal abnormalities abscess acute anal anastomosis ankylosing spondylitis antibiotics antigens arthritis associated azathioprine barium biopsies cancer carcinoma cells chronic clinical colectomy colitis and Crohn's colon colonoscopy complications controlled trial corticosteroids Crohn's colitis Crohn's disease diagnosis diarrhea diet dilatation disease activity disease and ulcerative distal dosage dose drug dysplasia endoscopic enemas epithelial evaluation factors fistulas Gastroenterology genetic histologic hydrocortisone IBD patients ileal ileoanal ileostomy ileum immunosuppressive improved increased inflammation inflammatory bowel disease intestinal intravenous involvement Lancet Lennard-Jones lesions manifestations methotrexate metronidazole mucosa normal obstruction occur oral parenteral nutrition patients with Crohn's patients with ulcerative perianal physician placebo pouch procedure prednisolone prednisone present proctitis prognosis rectal rectum recurrence relapse remission reported resection response risk serum side effects sigmoidoscopic small bowel steroids stool strictures sulfasalazine Surg surgery surgical symptoms therapeutic therapy tion tissue toxic megacolon treated Truelove ulcerative colitis usually